To evaluate the relationships between bone mineral markers levels at dialysis start and vascular calcification progression during a 2 year follow up
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
400
dosage of plasma osteoprotegerin
dosage of plasma fibroblast growth factor 23
measurement of vascular calcification score by X-ray of the lateral abdominal aorta
Centre Hémodialyse du Lez
Castelnau-le-Lez, France
RECRUITINGAIDER
Montpellier, France
RECRUITINGCHU Montpellier, Nephrology department
Montpellier, France
RECRUITINGProgression of vascular calcifications during a 2 year follow up according to plasma osteoprotegerin level at inclusion
osteoprotegerin will be measured in picomol/L; vascular calcifications will be measured at inclusion and after the 2 year follow up
Time frame: 2 years after inclusion
Progression of vascular calcifications during a 2 year follow up according to plasma fibroblast growth factor 23 level at inclusion
fibroblast growth factor 23 will be measured in RU/milliliter; vascular calcifications will be measured at inclusion and after the 2 year follow up
Time frame: 2 years after inclusion
Occurence of cardiovascular events during a 2 year follow up
Time frame: 2 years after inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CH Nimes, Nephrology department
Nîmes, France
RECRUITINGCH Perpignan, Nephrology department
Perpignan, France
RECRUITING